Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.48 |
| ▸ | NPC1 | O15118 | 4/20 | 0.48 |
| ▸ | RAB9A | P51151 | 4/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | CTSK | P43235 | 4/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | ACE | P12821 | 1/20 | 0.42 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | CTSL | P07711 | 1/20 | 0.42 |
| ▸ | CTSB | P07858 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL2946565 | 0.99 | SMN1; SMN2 (0.47) | SMN1; SMN2NPC1RAB9ALMNACTSK | |
| SCHEMBL2426331 | 0.84 | TSHR (0.54) | SMN1; SMN2NPC1RAB9ALMNACTSK | |
| SCHEMBL5668365 | 0.80 | TSHR (0.53) | SMN1; SMN2NPC1RAB9ALMNATDP1 | |
| SCHEMBL15094453 | 0.80 | NAAA (0.47) | CTSKALDH1A1POLBHPGDCTSL | |
| SCHEMBL5994752 | 0.80 | SRR (0.47) | NPC1RAB9ACYP1A2 | |
| SCHEMBL4688931 | 0.80 | TDP1 (0.49) | SMN1; SMN2NPC1RAB9ALMNACTSK | |
| SCHEMBL27230066 | 0.79 | TSHR (0.54) | SMN1; SMN2NPC1RAB9ALMNATDP1 | |
| SCHEMBL8583257 | 0.79 | ALPI (0.47) | NPC1RAB9ALMNAALDH1A1 | |
| SCHEMBL3425339 | 0.78 | ATM (0.51) | CTSKACECTSLCTSB | |
| SCHEMBL4669847 | 0.78 | EPHX1 (0.44) | SMN1; SMN2NPC1RAB9AL3MBTL1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2454246-A2 | SOLVATES OF DOCETAXEL | Przedsiebiorstwo Produkcyjno-Wdrozeniowe (PL) | 2012-05-23 | — | — | EP | claimed |
| WO-2010138010-A2 | SOLVATES OF 4-ACETOXY-2α-BENZOYLOXY-5β,20-EPOXY-1,7β,10β-TRIHYDROXY-9-OXO-TAX-11 -EN- 13α-YL (2R,3S)-3-TERT-BUTOXYCARBONYLAMINO-2-HYDROXY-3-PHENYLPROPIONATE | Przedsiębiorstwo Produkcyjno-Wdrożeniowe (PL) | 2010-12-02 | — | — | WO | claimed |
| EP-2247582-A2 | CRYSTALLINE FORMS OF DIMETHOXY DOCETAXEL AND METHODS FOR PREPARING SAME | Aventis Pharma S.A. (FR) | 2010-11-10 | — | — | EP | claimed |
| WO-2009115655-A2 | CRYSTALLINE FORMS OF DIMETHOXY DOCETAXEL AND METHODS FOR PREPARING SAME | AVENTIS PHARMA S.A. (FR) | 2009-09-24 | — | — | WO | claimed |
| EP-1667986-A1 | DIMETHOXY DOCETAXEL ACETONE SOLVATE ET METHOD FOR THE PREPARATION THEREOF | Aventis Pharma S.A. (FR) | 2006-06-14 | — | — | EP | claimed |
| WO-2005028462-A1 | DIMETHOXY DOCETAXEL ACETONE SOLVATE ET METHOD FOR THE PREPARATION THEREOF | AVENTIS PHARMA S.A. (FR) | 2005-03-31 | — | — | WO | claimed |
| EP-1176957-A1 | METHOD FOR TREATING ABNORMAL CELL PROLIFERATION IN THE BRAIN | Aventis Pharma S.A. (FR) | 2002-02-06 | — | — | EP | claimed |
| WO-2000066113-A1 | METHOD FOR TREATING ABNORMAL CELL PROLIFERATION IN THE BRAIN | AVENTIS PHARMA S.A. (FR) | 2000-11-09 | — | — | WO | claimed |
| EP-0876361-A1 | 4,10$g(b)-DIACETOXY-2$g(a)-BENZOYLOXY-5$g(b),20-EPOXY-1-HYDROXY-9-OXO-19-NOR-CYCLOPROPA G]TAX-11-ENE-13$g(a)-YL (2R,3S)-TERT-BUTOXYCARBONYLAMINO-2-HYDROXY-3-PHENYLPROPIONATE DIHYDRATE, AND METHOD FOR PREPARING SAME | Aventis Pharma S.A. (FR) | 1998-11-11 | — | — | EP | claimed |
| WO-1997021695-A1 | 4,10β-DIACETOXY-2α-BENZOYLOXY-5β,20-EPOXY-1-HYDROXY-9-OXO-19-NOR-CYCLOPROPA[G]TAX-11-ENE-13α-YL (2R,3S)-TERT-BUTOXYCARBONYLAMINO-2-HYDROXY-3-PHENYLPROPIONATE DIHYDRATE, AND METHOD FOR PREPARING SAME | RHONE-POULENC RORER S.A. (FR) | 1997-06-19 | — | — | WO | claimed |
| EP-3258931-A1 | USE OF CABAZITAXEL IN THE TREATMENT OF PROSTATE CANCER | Erasmus University Medical Center Rotterdam (NL) | 2017-12-27 | — | — | EP | disclosed |
| WO-2016133387-A1 | USE OF CABAZITAXEL IN THE TREATMENT OF PROSTATE CANCER | ERASMUS UNIVERSITY MEDICAL CENTER ROTTERDAM (NL) | 2016-08-25 | — | — | WO | disclosed |
| WO-2015104417-A1 | USE OF CABAZITAXEL FOR THE TREATMENT OF GASTRIC ADENOCARCINOMA | AVENTIS PHARMA S.A. (FR) | 2015-07-16 | — | — | WO | disclosed |
| WO-2015036507-A1 | USE OF CABAZITAXEL IN PATIENTS WITH METASTATIC NSCLC PROGRESSING AFTER DOCETAXEL-BASED TREATMENT | AVENTIS PHARMA S.A. (FR) | 2015-03-19 | — | — | WO | disclosed |
| EP-2493466-A1 | NOVEL ANTITUMORAL USE OF CABAZITAXEL | Aventis Pharma S.A. (FR) | 2012-09-05 | — | — | EP | disclosed |
| WO-2000066113-A1 | METHOD FOR TREATING ABNORMAL CELL PROLIFERATION IN THE BRAIN | AVENTIS PHARMA S.A. (FR) | 2000-11-09 | — | — | WO | disclosed |
| EP-0876361-A1 | 4,10$g(b)-DIACETOXY-2$g(a)-BENZOYLOXY-5$g(b),20-EPOXY-1-HYDROXY-9-OXO-19-NOR-CYCLOPROPA G]TAX-11-ENE-13$g(a)-YL (2R,3S)-TERT-BUTOXYCARBONYLAMINO-2-HYDROXY-3-PHENYLPROPIONATE DIHYDRATE, AND METHOD FOR PREPARING SAME | Aventis Pharma S.A. (FR) | 1998-11-11 | — | — | EP | disclosed |
| WO-1997021695-A1 | 4,10β-DIACETOXY-2α-BENZOYLOXY-5β,20-EPOXY-1-HYDROXY-9-OXO-19-NOR-CYCLOPROPA[G]TAX-11-ENE-13α-YL (2R,3S)-TERT-BUTOXYCARBONYLAMINO-2-HYDROXY-3-PHENYLPROPIONATE DIHYDRATE, AND METHOD FOR PREPARING SAME | RHONE-POULENC RORER S.A. (FR) | 1997-06-19 | — | — | WO | disclosed |
| EP-0770070-A1 | METHOD FOR PREPARING 4-ACETOXY-2ALPHA-BENZOYLOXY-5ALPHA,20-EPOXY-1,7BETA,10BETA-TRIHYDROXY-9-OXO-TAX-11-EN-13ALPHA-YL(2R,3S)-3-TERT-BUTOXYCARBONYLAMINO-2-HYDROXY-3-PHENYLPROPIONATE TRIHYDRATE | Aventis Pharma S.A. (FR) | 1997-05-02 | — | — | EP | disclosed |
| WO-1996001815-A1 | METHOD FOR PREPARING 4-ACETOXY-2α-BENZOYLOXY-5β,20-EPOXY-1,7β,10β-TRIHYDROXY-9-OXO-TAX-11-EN-13α-YL(2R,3S)-3-TERT-BUTOXYCARBONYLAMINO-2-HYDROXY-3-PHENYLPROPIONATE TRIHYDRATE | RHONE-POULENC RORER S.A. (FR) | 1996-01-25 | — | — | WO | disclosed |